A Changing Landscape Regulatory Impact on Medication Management

Size: px
Start display at page:

Download "A Changing Landscape Regulatory Impact on Medication Management"

Transcription

1 2015 Remedi SeniorCare Annual Conference August 30, 2018 A Changing Landscape Regulatory Impact on Medication Management William M. Vaughan RN Vice President, Education / Clinical Affairs Remedi SeniorCare 1 DISCLOSURE / CONTACT INFO Remedi SeniorCare Clinical Advisory Board ISMP LTC Newsletter william.vaughan@remedirx.com 2 Welcome to the ISMP Long-Term Care Advise-ERR, a medication safety newsletter designed specifically to meet the needs of administrators, nursing directors, and nurses who transcribe medication orders, administer medications, monitor the effects of medications on residents, and/or supervise those who carry out these important tasks. 3

2 2015 Remedi SeniorCare 4 REGULATIONS F 756: Drug Regimen Review F 758: Psychotropic drugs F 881: Infection prevention / control - ABT stewardship F 552: Planning / Implementing Care Remedi SeniorCare TIME FOR LOW BUDGET REMEDI JEOPARDY Remedi SeniorCare

3 2015 Remedi SeniorCare Source: ProPublica (updated June, 2018) 7 Source: ProPublica (updated June, 2018) Remedi SeniorCare Source: ProPublica (updated June, 2018) Remedi SeniorCare

4 DEFICIENCY DATA: PHASE II 11/28/17 7/31/18 F 756: DRUG REGIMEN REVIEW F758: PSYCHOTROPIC DRUGS F881: ANTIBIOTIC STEWARDSHIP F 552: PLANNING/IMPLEMENT CARE OHIO DEFICIENCIES ALL F TAGS = 3, DATA SOURCES 1) Data portal 2) Aggregate health deficiencies cited in federally certified nursing homes 3) Redacted deficiencies for specific nursing homes 4) Unredacted deficiencies for specific nursing homes Accessed: August 19, 2018 Caution: Delay in posting survey results / look back period/redaction 11 F 756 DRUG REGIMEN REVIEW Mega Rule: Medical record Medical Director Policies / Procedures Ohio Total = 49 D = 44 E = 5 F Total = G = 1 0 A B C D E F G Scope/Severity 12

5 DEFINITION: DRUG IRREGULARITY use of medication that is inconsistent with accepted standards of practice for providing pharmaceutical services, not supported by medical evidence, and/or that impedes or interferes with achieving the intended outcomes of pharmaceutical services. An irregularity also includes, but is not limited to, use of medications without adequate indication, without adequate monitoring, in excessive doses, and/or in the presence of adverse consequences, as well as the identification of conditions that may warrant initiation of medication therapy. - Guidance to Surveyors: F DEFINITION: PHARMACEUTICAL SERVICES The process (including documentation, as applicable) of receiving and interpreting prescriber s orders; acquiring, receiving, storing, controlling, reconciling, compounding (e.g., intravenous antibiotics), dispensing, packaging, labeling, distributing, administering, monitoring responses to, using and/or disposing of all medications, biologicals, chemicals (e.g., povidone iodine, hydrogen peroxide); The provision of medication-related information to health care professionals and residents; The process of identifying, evaluating and addressing medication-related issues including the prevention and reporting of medication errors; and The provision, monitoring and/or the use of medication-related devices - Guidance to Surveyors: F F 756 DRUG REGIMEN REVIEW Ohio (E level) Failure to report / respond / implement recommendations An interview with the Director of Nursing (DON) on 04/20/18 at 3:30 P.M. revealed she was new to the position since 03/29/18. The DON verified she was not able to find the pharmacy recommendations or the physician follow up on the recommendations. Review of Resident # 40's Pharmacy Consultation Report for 01/01/18 to 01/18/18 revealed the resident received a sulfonylurea and Glimepiride (to treat diabetes). Please consider titrating Glimepiride and discontinuing sliding scale insulin therapy. The Certified Nurse Practitioner (CNP) checked, I accept the recommendations above, please implement as written. However, no evidence was found of an order written [survey date: 4/25/18]

6 2015 Remedi SeniorCare Remedi SeniorCare Remedi SeniorCare

7 F 756 DRUG REGIMEN REVIEW Ohio (E level) Failure to report / respond / implement recommendations Further review of the report on 03/12/18 revealed there was no evidence the doctor responded to the report. On 03/06/18 at 3:15 P.M., interview with the director of nursing (DON) verified if the pharmacy recommendations were for the psychiatrist they would go in his box but he did not come into the facility that often and there was no system in place to ensure the recommendations were addressed timely. The attending physician must document in the resident s medical record that the identified irregularity has been reviewed and what, if any, action has been taken to address it. 19 F 756 DRUG REGIMEN REVIEW Ohio (E level) Failure to report / respond / implement recommendations On 03/07/18 at 6:05 P.M., during interview, the DON stated she received the pharmacist's recommendations then placed them in the appropriate physicians' folders for responses. The DON verified Resident #39's recommendations which were responded to were not responded to in a timely manner. The DON verified she had no system in place to ensure recommendations were responded to in a timely manner. After the recommendations were placed in the physicians' folders, she simply waited to get the form with a response. Medical Director??? 20 F 756 DRUG REGIMEN REVIEW Ohio (E level) Failure to report / respond / implement recommendations On 01/18/18 at 1:44 P.M., interview with the Director of Nursing verified the pharmacy identified a potential drug interaction, the facility did not notify the resident's physician prior to administration and did not monitor the resident for potential adverse reactions. Reported to the facility by dispensing pharmacist Administered x 2 days before physician was notified drug discontinued 21

8 F 756 DRUG REGIMEN REVIEW Failure to identify irregularity PRN psychotropic > 14 days No justification/duration in the record Failure to respond to recommendations timely During an interview on at 8:34 AM, the Administrator stated that the DON was unable to locate any pharmacy recommendations for prior months. S/he said that reports had been going to the DON who has just been setting them aside. Failure to maintain recommendations in the record Policy 9.1 Medication Regimen Review (MRR), Procedure 12. revealed that the Facility should maintain readily available copies of MRRs on file in Facility as part of the resident's permanent health record. 22 F 756 DRUG REGIMEN REVIEW (actual harm) Failure to report recommendations timely When interviewed, the Director of Nurses stated that the numerous pharmacy recommendations were not reviewed by facility staff and were not sent to the physician to be followed up on because they were too busy. Multiple falls fractured hip (attributed, in part, to medications referenced in several unanswered pharmacy recommendations) 23 F 756 DRUG REGIMEN REVIEW Medical director and pharmacy recommendations, your experience? Recent survey: The DON must sign the pharmacy recommendations Recent IDR: 3/15: Glucosamine 1500 mg one tab bid 3/15: Dispensed two 750 mg tabs MAR not corrected 5/1: Survey med pass observation -- > one tab documented, two administered Deficiency: F 756 (D) The pharmacist failed to report the discrepancy IDR: regulation, scope of practice, resource burden A level The problem broad definition of irregularity 24

9 What's wrong with this picture? - Actual deficiency cited June 7, Mega Rule: Definition Processes (indication, non-pharm, GDR) PRN limits Ohio Total = 72 D = 66 E = 5 J = 1 F Total = 1,123 0 A B C D E F G J J = 2 Scope/Severity Ohio Failure to document indication Failure to attempt GDR All 4 classes Failure to monitor individualized target behavior Failure to address via comprehensive care plan Failure to attempt non-pharm intervention 27

10 Ohio Failure to attempt non-pharm intervention Interview on 01/11/18 at 9:48 A.M., with the Director of Nursing (DON) confirmed, after reviewing Resident #43's medical progress notes, there was no documented evidence of any non-pharmalogical interventions attempted prior to the staff administering the as needed Haldol injection to Resident #43 No documentation of non pharmacological interventions being attempted prior to the staff administering as needed pain or anti anxiety medications to Resident #5. 28 Staff administered an as needed (PRN) Antipsychotic Medication to Resident #101 on multiple occasions without attempting other measures before using the drug the Minimum Data Set (MDS) Coordinator stated the nurses had not entered information into the system correctly to activate a prompt which asks what nonpharmacological measures have been attempted prior to administering the medication Failure to monitor behaviors /side effects Interview with the Director of Nursing (DON) revealed the order for antipsychotic monitoring was discontinued by the physician. The DON was unable to clarify why the order had been discontinued. PRN > 14 days No rationale / duration Failure to use non-pharmacological interventions PRN anti-anxiety (20x) PRN antipsychotic All of the above in one resident.prn antipsychotic was administered 20 times over a period of 22 days without evidence of assessment to determine the underlying cause of exhibited behaviors, attempts at non-pharmacological interventions prior to administration, or physician evaluation of continued need.

11 The Assistant Director of Nursing (ADON) was interviewed and asked of the expectation of nurses before giving PRN pain medications. ADON stated I would expect them to assess the resident first. They are also supposed to try things such as giving water, turning on music and changing position before they pop something down their throats 31 The Assistant Director of Nursing (ADON) was interviewed and asked of the expectation of nurses before giving PRN pain medications. ADON stated I would expect them to assess the resident first. They are also supposed to try things such as giving water, turning on music and changing position before they pop something down their throats 32 The Assistant Director of Nursing (ADON) was interviewed and asked of the expectation of nurses before giving PRN pain medications. ADON stated I would expect them to assess the resident first. They are also supposed to try things such as giving water, turning on music and changing position before they pop something down their throats (c)(3) A psychotropic drug is any drug that affects brain activities associated with mental processes and behavior. These drugs include, but are not limited to, drugs in the following categories: (i) Anti-psychotic; (ii) Anti-depressant; (iii) Anti-anxiety; and (iv) Hypnotic 33

12 The Assistant Director of Nursing (ADON) was interviewed and asked of the expectation of nurses before giving PRN pain medications. ADON stated I would expect them to assess the resident first. They are also supposed to try things such as giving water, turning on music and changing position before they pop something down their throats 34 Failure to attempt GDR The pharmacist recommended Resident #1 be reviewed for a gradual dose reduction on 12/17/17. There had been no response to the recommendation when the surveyor was at the facility 1/30-1/31/18 Review of the Doctor's Progress Notes revealed no documentation between 12/17/17 and 1/31/18 related to the pharmacist recommendations for a gradual dose reduction there was no current documentation of clinical contraindications. 35 PRN > 14 days 11/2/17: Anti-anxiety medication order tid PRN (no stop date) - administered almost daily 12/22/17: Consultant pharmacist review either d/c or consider routine dosing MD discontinue (documented on pharmacy recommendation) 1/4/18: Surveyor review: Order remains tid PRN, administered almost daily Interview with the director of nursing revealed that the resident was still on the medication because the facility disagreed with the physician's assessment and held the order to discontinue for the nurse practitioner to review the nurse manager left it to the DON to call the physician and request routine dosing, but the DON was gone that week and the matter was not handled until 1/4/18 [after surveyor intervention] 36

13 YOU ARE NOW THE SURVEYOR: SCOPE/SEVERITY? 37 YOU ARE NOW THE SURVEYOR: SCOPE/SEVERITY? Immediate Jeopardy - A situation in which the provider s noncompliance with one or more requirements of participation has caused, or is likely to cause, serious injury, harm, impairment, or death to a resident. - Appendix Q 38 Ohio(IJ) Psychiatrist prescribed Trilifan to a resident in error based on misinformation from the nursing staff administered x 45 days lethargy, decreased intake, decreased activities, decline ADLs surveyor intervention 39

14 (IJ) Admit from home on hospice within 2 weeks, seen by psych, ordered Haldol.25 mg bid x 14 days (no indication in the record) using EHR, nursing inputs Haldol 20 mg bid dispensed 4 doses hospitalization (ADR / overdose) Federal CMP: $ 98, Mega Rule: Establish program Use protocols System to monitor Ohio Total = 13* 41 C = 1, D = 6, E = 2, F = 4 Total = 259* Nothing > F Majority = F F 881 A B C D E F G Scope/Severity Ohio (C) Failure to implement program Interview conducted on 05/03/18 at 1:57 P.M. with Nurse #26 revealed the facility had no documentation of the antibiotic stewardship program nor any infection control log for the months of January, February, and March. She stated the infection control program was undocumented for three months because the employee responsible for collecting the data no longer worked for the facility. 42

15 Ohio (F) Failure to implement program Review of the facility's infection control log revealed no evidence the facility implemented an Antibiotic Stewardship Program. On 05/09/18 at 10:45 A.M. interview with Registered Nurse (RN) #12 verified the facility had not implemented an antibiotic stewardship program to date. 43 Ohio (F) Policy The facility failed to ensure residents receiving antibiotic therapy were properly assessed, evaluated and educated before the initiation of the antibiotic therapy. The Director of Nursing (DON) confirmed the facility was not appropriately evaluating antibiotics given to residents. The DON verified the facility was not following up and assessing residents who were receiving antibiotics according to their policy. Review of the policy revealed the use of the antibiotics will be monitored in all residents with appropriate lab work. Antibiotics orders will be reviewed for appropriateness and clarification with the physicians as needed. If and when antibiotics were prescribed over the phone, the physician will assess the resident within 72 hours. 44 Failure to establish program In an interview on 04/19/18 at 11:40 a.m. the RDO said they did not currently have an antibiotic stewardship program up and running In an interview on 04/19/18 at 12:20 p.m., the Administrator said she was not aware that the facility had not started the antibiotic stewardship program Interview on 5/18/18 with the DON revealed the facility has not instituted antibiotic stewardship program. She stated the consultant pharmacy brought her a policy and procedure and the corporate nurse brought a better policy. DON stated she is not instituted the policy yet because she is acting as interim DON and will leave as soon On 5/23/18 at 3:00 PM, Administrative Nurse D stated he/she managed the infection control program and verified the logs were not complete. Administrative Nurse D stated there were multiple urinary tract infections, including several on one hallway, and he/she verified the facility had no antibiotic stewardship program in place. 45

16 Failure to follow protocols The facility failed to accurately implement the protocols using the Surveillance Data Collection Form established by the facility, to ensure residents reviewed for infections with antibiotics were screened correctly. The form did not include the check marks to indicate if the criteria was met for the use of the antibiotic. (California) According to the Centers for Disease Control and Prevention (CDC), there are identified core elements/actions a nursing home should ensure to prevent antibiotic resistance. The nursing home should: 1. Educate their providers on the potential harm of antibiotics. 2. Document the met criterias for the use of the antibiotic and making this information accessible (e.g., verifying indication and planned duration is documented on transfer paperwork) helps ensure that antibiotics can be modified as needed based on additional laboratory and clinical data and/or discontinued in a timely manner to reduce unnecessary antibiotic exposure and improve resident outcomes 46 Does F 881 require that facilities incorporate CDC s core elements of antibiotic stewardship into their use protocols and monitoring system? 47 The facility must develop an antibiotic stewardship program which includes the development of protocols and a system to monitor antibiotic use. This development should include leadership support and accountability via the participation of the medical director, consulting pharmacist, nursing and administrative leadership, and individual with designated responsibility for the infection control program if different 48 - Guidance to Surveyors F 881

17 surveyors must base all cited deficiencies on a violation of statutory and/or regulatory requirements, rather than sections of the interpretive guidelines. The deficiency citation must be written to explain how the entity fails to comply with the regulatory requirements, not how the facility fails to comply with the guidelines for the interpretation of those requirements. -CMS memorandum S&C Protocols: Up to 75 percent of antibiotics prescribed in nursing homes are prescribed incorrectly. The most common prescribing problems in nursing homes are using an antibiotic when not needed, choosing the wrong antibiotic, and using the correct antibiotic but for the wrong dose or duration. - Center for Disease Control and Prevention 50 Failure to assess for continued use The DON acknowledged the resident's course for the use of the antibiotic had not been assessed or monitored. The DON verified the facility lacked documented evidence of a rationale for the continued administration of the antibiotic from 02/02/18 to 05/22/18. The Physician's Assistant (PA) acknowledged the resident had been on the antibiotic since 02/02/18. The PA indicated the infection was colonized as the resident had been on the antibiotic for an extended period of time. The PA indicated the resident was supposed to see a pulmonologist. The PA indicated the pulmonologist would have made recommendations regarding the continued administration of the antibiotic. The PA indicated there was a lack of documented evidence a rationale for the continued use of the antibiotic. 51

18 YOU ARE NOW THE SURVEYOR: SCOPE/SEVERITY? Immediate Jeopardy - A situation in which the provider s noncompliance with one or more requirements of participation has caused, or is likely to cause, serious injury, harm, impairment, or death to a resident. - Appendix Q 52 Failure to communicate laboratory results 4/21: UA findings positive for a urinary tract infection. [indication for UA not specified] MD call Cipro bid x 5 days (1 st dose administer 4/23) 4/23: C&S resistant to Cipro no MD notification Cipro administered x 5 days The ADON said the facility was still in the process of developing an antibiotic stewardship program and did not have a policy and procedure to provide. 53 Standardized tool /criteria for diagnosis Timely administration Communication Antibiotic time out Black box warning Because the risk of these serious side effects generally outweighs the benefits for patients with acute bacterial sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections, the FDA has determined that fluoroquinolones should be reserved for use in patients with these conditions who have no alternative treatment options. 54

19 2015 Remedi SeniorCare 55 Bottom Line Develop a program (Streamline) Follow the program Do the basics F 552: PLANNING / IMPLEMENTING CARE Mega Rule: In advance Qualified staff Risks / benefits / alternatives Ohio Total = 4* D = 4 Total = 125* C = 1 F = 2 G = F 552 A B C D E F G Scope/Severity

20 Ohio F 552: IMPLEMENTING / PLANNING CARE The facility failed to ensure a resident's request for a change of time regarding medication was accommodated. Midodrine prior to dialysis The facility failed to ensure Resident Rights were maintained regarding medication administration. Medication error: roommate s insulin Resident #166 stated I told the nurse the medications were for my roommate but she just lifted by shirt and gave the medicine in my stomach. I don't have any hard feelings toward the nurse and I feel fine. I have diabetes but don't take insulin 58 Ohio F 552: IMPLEMENTING / PLANNING CARE The facility failed to ensure a resident who wore hand brace/splints was consulted in the wearing schedule. Interview on 03/29/18 at 02:17 P.M. with TPM #610 confirmed the resident was not involved in her decisions for her care related to the splints. 59 F 552: IMPLEMENTING / PLANNING CARE (C) The facility failed to inform residents of the need to perform extensive inspection and subsequent cleaning procedures in residents' rooms due to the identification of bed bugs in the facility a facility employee discovered a bug on herself. All facility rooms were inspected and two live and three dead bed bugs were found on a resident s bed the whole facility was treated for bed bugs. This treatment required that all residents be out of their rooms and placed in either the activity room or dining room for a period of approximately two to four hours interview with the DON indicated that the residents' responsible parties were made aware of the bed bugs and treatment, but the facility did not tell the residents being relocated for approximately fours hours to the common areas of the actual reason for the relocation. 60

21 F 552: IMPLEMENTING / PLANNING CARE (F?) The facility failed to ensure Resident 116 was allowed to participate in his treatment plan for pain medication administration and maintain acceptable pain levels. Lower leg amputation multiple PRN orders to treat pain (no routine meds) Resident 116 stated he had an amputation three days ago and still feels pain. Resident 116 further stated I'm blind but still feel pain 9/10 (On a pain scale of 0-10, 0-no pain to 10-extreme pain) to the left foot. Resident 116 stated he requested to have his pain medications administered routinely but his request was denied There no documentation that facility staff had met with Resident 116 regarding his desire to have his pain medications given routinely 61 F 552: IMPLEMENTING / PLANNING CARE (F?) The facility failed to inform residents in advance of the risks and benefits of proposed care and treatment for 1of 17 residents reviewed for resident rights in that Residents #61 did not have signed consents for pychoactive medications. This failure affected 1 resident who received psychoactive medications without informed consents and placed 67 other residents at risk of receiving treatments without informed consent Resident #61's family member and Power of Attorney said that no one had called to get her consent for medications but said that she would give it. 62 F 552: IMPLEMENTING / PLANNING CARE (G) Failure to contact correct health care decision-maker with change in condition 4 day delay in hospitalization 11/3/17: new onset left side weakness NP contacted, send to hospital alternate health care agent contacted, treat in house 11/7/17: neurological symptoms progressed hospitalized (alternate health care agent informed) 1/2/18: surveyor interview of primary health care agent never informed of change in condition, subsequent hospitalization or potential clinical interventions to prevent progression of stroke 63

22 64 F 552: IMPLEMENTING / PLANNING CARE (E) Based on observation, interview and record review, the facility failed to ensure two residents (Resident 133 and Resident 339) were explained about their medications, prior to the administration. This deficient practice had the potential to result in violating the resident's right to be informed, in order to be able to accept or refuse their treatments LVN 5 acknowledged he had not explained any of the medications to Resident 133 prior to administering the medications. LVN 5 further stated, We need to tell the residents what medications they are receiving. They have a right to know. LVN 6 stated I do not tell the residents what medications they are taking unless there is a new medication because they (residents' medications) are all the same each time. I do not know if that is the right way to go about it. Prior to administration of every medication, every time! F 552: IMPLEMENTING / PLANNING CARE What is your process? Risks/Benefits/Alternatives How much is enough? Black box warnings? Which staff member? Documentation? Signed consent? Unavailability of surrogate? QAPI data 65 Themes F 552: IMPLEMENTING / PLANNING CARE Psychotropic drugs Antipsychotics Antidepressants Timing Admission Prior to each dose Documentation Resident versus responsible party Hospice 66

23 2015 Remedi SeniorCare Remedi SeniorCare

HOW WE GOT HERE 1935: Social Security Act Private nursing homes

HOW WE GOT HERE 1935: Social Security Act Private nursing homes 1 LeadingAge Oklahoma Annual Conference March 8, 2017 CMS Revised Pharmacy Regulations: Lessons Learned from Phase 1, Guidance for Phase 2 William M. Vaughan RN, BSN Vice President, Education and Clinical

More information

Pharmacy Services. Division of Nursing Homes

Pharmacy Services. Division of Nursing Homes Pharmacy Services Division of Nursing Homes 1 483.45 Pharmacy Services Overview The Pharmacy Services section of Appendix PP contains all Pharmacy Services requirements and interpretive guidelines (IG)

More information

Medication Related Changes Phase 1&2

Medication Related Changes Phase 1&2 Medication Related Changes Phase 1&2 Medicare and Medicaid Programs Reform of Requirements for Long-Term Care Facilities Published January 23, 2017 Medication- Related Changes* Changes will be implemented

More information

3/6/2017. CMS nursing home requirements have not been comprehensively updated since 1991 despite significant changes in the industry.

3/6/2017. CMS nursing home requirements have not been comprehensively updated since 1991 despite significant changes in the industry. Debra Brown, PharmD Pharmaceutical Consultant II Specialist Licensing and Certification QCHF/CAHF Spring Legislative Conference March 2017 1 Describe impact of 2016 CMS Final Rule on SNF pharmacy services

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Use for a resident who has potentially unnecessary medications, is prescribed psychotropic medications or has the potential for an adverse outcome to determine whether facility practices are in place to

More information

Pharmaceutical Services Instructor s Guide CFR , (a)(b)(1) F425

Pharmaceutical Services Instructor s Guide CFR , (a)(b)(1) F425 Centers for Medicare & Medicaid Services (CMS) Pharmaceutical Services Instructor s Guide CFR 483.60, 483.60(a)(b)(1) F425 2006 Prepared by: American Institutes for Research 1000 Thomas Jefferson St, NW

More information

CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW

CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW CMS RULES FOR PARTICIPATION/LTC REGULATIONS: WHAT YOU NEED TO KNOW SATURDAY/3:15-4:15PM ACPE UAN: 0107-9999-17-242-L04-P 0.1 CEU/1.0 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists:

More information

CMS Mega Rule: Implications for Pharmacists and Pharmacies

CMS Mega Rule: Implications for Pharmacists and Pharmacies CMS Mega Rule: Implications for Pharmacists and Pharmacies Curt Wood, RPh, BCGP, FASCP Disclosure and Conflict of Interest Curt Wood declares no conflicts of interest, real or apparent, and no financial

More information

The CMS State Operations Manual Overview and Changes

The CMS State Operations Manual Overview and Changes The CMS State Operations Manual Overview and Changes Omnicare, Inc. Page 1 Overview of the CMS State Operations Manual Executive Summary Historical Perspective The Requirements Pharmacy Services Labeling

More information

Reviewing regulatory requirements for top ten federal Nursing Home Tags issued in Minnesota. Eva Loch, MDH Nursing Evaluator

Reviewing regulatory requirements for top ten federal Nursing Home Tags issued in Minnesota. Eva Loch, MDH Nursing Evaluator Reviewing regulatory requirements for top ten federal Nursing Home Tags issued in Minnesota. Eva Loch, MDH Nursing Evaluator F282- Comprehensive Care Plans Regulatory language (SOM): 483.21(b)(3) Comprehensive

More information

Psychotropic Drug Use To Medicate or Not to Medicate?

Psychotropic Drug Use To Medicate or Not to Medicate? Psychotropic Drug Use To Medicate or Not to Medicate? Presented by: Lydia Restivo, RN CDONA Regulatory Compliance Consultant West & Restivo Quality Consulting Cell: 516 318-9088 Email: lydrestivo@verizon.net

More information

The Consultant Pharmacist: The IDT Approach to Pharmacotherapy Care and Compliance with the CMS Final Rule

The Consultant Pharmacist: The IDT Approach to Pharmacotherapy Care and Compliance with the CMS Final Rule The Consultant Pharmacist: The IDT Approach to Pharmacotherapy Care and Compliance with the CMS Final Rule Dr. William G. Day Continuing Education Information 1.0 contact hours of continuing education

More information

Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications

Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications Developing and Action Plan: Person Centered Dementia Care and Psychotropic Medications Lisa Bridwell Program Specialist Telligen QIN-QIO March 2018 Objectives Review interpretive guidance F758 (Free from

More information

The Changing Role of Physicians in LTCF

The Changing Role of Physicians in LTCF The Changing Role of Physicians in LTCF David Gifford MD MPH Boise ID Feb 9 th, 2017 CMS Changes to SNF Regs New rule makes extensive changes to SNF Requirements of Participation (RoP) Last major update

More information

Highlights of the New LTCSP and Regulations

Highlights of the New LTCSP and Regulations Highlights of the New LTCSP and Regulations New York State Department of Health Division of Nursing Homes and ICF/IID Surveillance November 15, 2017 November 15, 2017 2 Resources https://www.cms.gov/medicare/provider-enrollment-andcertification/guidanceforlawsandregulations/nursinghomes.html

More information

Copyrighted - American Society of Consultant Pharmacists - September 29,

Copyrighted - American Society of Consultant Pharmacists - September 29, Practical Tips to Prepare for and Implement the New Pharmacy Sections of the Nursing Home Survey Guidelines Carla Saxton McSpadden, RPh, CGP Assistant Director of Policy and Advocacy American Society of

More information

Form CMS (5/2017) Page 1

Form CMS (5/2017) Page 1 Use this pathway for a resident who has pain symptoms or can reasonably be expected to experience pain (i.e., during therapy) to determine whether the facility has provided and the resident has received

More information

Wyoming State Survey Agency

Wyoming State Survey Agency LeadingAge Wyoming September 6, 2018 Wyoming State Survey Agency Laura Hudspeth, MSc, RD, LD, Director Pat Davis, PE, LEED AP, Life Safety and Construction Branch Chief Julia Van Dyke, RN, Healthcare Surveillance

More information

Caring in the Carolinas 11/5/2016

Caring in the Carolinas 11/5/2016 The Mega Rule: Reform of Requirements for Long- Term Care Facilities Robert Smith, Pharm D, BCPS, CGP, FASCP Director of Clinical Services Neil Medical Group Disclosures I have no conflicts of interest

More information

Hey Recruit? You Ready for This?

Hey Recruit? You Ready for This? Pharmacy Regulations 101: Understanding the good, the bad and the ugly within the Interpretive Guidelines. Presented By: Dr. William G. Day Hey Recruit? You Ready for This? 1 Objectives Participants should

More information

Session # R05 May 1, 2014

Session # R05 May 1, 2014 Session # R05 May 1, 2014 Navigating the Regulatory Landscape: Guidance from a Former Surveyor Rob Shulman, RPh., CGP, FASCP Regional Director of Clinical Services Remedi SeniorCare William M. Vaughan,

More information

Update on the Mega Rule

Update on the Mega Rule Update on the Mega Rule What is it looking like already? Joanne Hirshfield, RPh, FASCP, MBA, BCGP President-Elect American Society of Consultant Pharmacists Texas State Chapter ASCP January 27, 2017 Disclosure

More information

Nursing Home Pearls or

Nursing Home Pearls or Nursing Home Pearls or How to Enjoy Practicing in Skilled Nursing Facilities Lowell C. Dale, MD November 11, 2016 2016 MFMER slide-1 DISCLOSURE Relevant Financial Relationship Medical Director Golden Living

More information

Part 1: Overview of AHCA/NCAL Clinical Considerations of Antipsychotic Management Toolkit

Part 1: Overview of AHCA/NCAL Clinical Considerations of Antipsychotic Management Toolkit Part 1: Overview of AHCA/NCAL Clinical Considerations of Antipsychotic Management Toolkit Dr. Cathy Lipton, MD Dr. Anna Fisher, PhD Holly Harmon, RN, MBA, LNHA Introduction Holly Harmon 1 Objectives Summarize

More information

What to Expect on Your Next Survey

What to Expect on Your Next Survey What to Expect on Your Next Survey Linda M. Elizaitis RN, BS, RAC-CT President CMS Compliance Group, Inc. E. lmelizaitis@cmscg.net T. 631.692.4422 cmscompliancegroup.com @lindaelizaitis @cmscompliance

More information

InformRx. Transition from Hospital to the LTC Facility: Preventing Medication Errors to Reduce Risk of Hospital Readmission

InformRx. Transition from Hospital to the LTC Facility: Preventing Medication Errors to Reduce Risk of Hospital Readmission CLINICAL & REGULATORY NEWS BY PHARMERICA NOV/DEC 2016 Transition from Hospital to the LTC Facility: Preventing Medication Errors to Reduce Risk of Hospital Readmission Transition from the hospital to the

More information

PHARMACY SERVICES/MEDICATION USE

PHARMACY SERVICES/MEDICATION USE 25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and

More information

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431 Centers for Medicare & Medicaid Services (CMS) Storage, Labeling, Controlled Medications Instructor s Guide CFR 483.60(b)(2)(3)(d)(e) F431 2006 Prepared by: American Institutes for Research 1000 Thomas

More information

NEW LONG TERM CARE SURVEY PROCESS PHASE 2 REQUIREMENTS OF PARTICIPATION AUGUST 23, 2017

NEW LONG TERM CARE SURVEY PROCESS PHASE 2 REQUIREMENTS OF PARTICIPATION AUGUST 23, 2017 NEW LONG TERM CARE SURVEY PROCESS PHASE 2 REQUIREMENTS OF PARTICIPATION AUGUST 23, 2017 Disclaimer: The information contained in this presentation is representative of the current information provided

More information

Update on Pharmacy Issues in Long Term Care Lisa Nichols RPh, CGP

Update on Pharmacy Issues in Long Term Care Lisa Nichols RPh, CGP Update on Pharmacy Issues in Long Term Care Lisa Nichols RPh, CGP 1.Review What a Consultant Pharmacist Does and the Role of Pharmacy for Long Term Care Facilities 2.Identify Key Components of a Medication

More information

483.45(b) Service Consultation. The facility must employ or obtain the services of a licensed pharmacist who

483.45(b) Service Consultation. The facility must employ or obtain the services of a licensed pharmacist who F755 483.45 Pharmacy Services The facility must provide routine and emergency drugs and biologicals to its residents, or obtain them under an agreement described in 483.70(g). The facility may permit unlicensed

More information

Examining Inappropriate Use of Antipsychotic Drugs Part One: How Seven States Cite Antipsychotic Drug Deficiencies

Examining Inappropriate Use of Antipsychotic Drugs Part One: How Seven States Cite Antipsychotic Drug Deficiencies Examining Inappropriate Use of Antipsychotic Drugs Part One: How Seven States Cite Antipsychotic Drug Deficiencies The misuse of antipsychotic drug is a pervasive problem in American nursing facilities.

More information

CMS Final Rule Pharmacy Services Update: What You Need to Know!

CMS Final Rule Pharmacy Services Update: What You Need to Know! CMS Final Rule Pharmacy Services Update: What You Need to Know! Presented by: Dr. William C. Hallett, Pharm.D., MBA, CGP, C-MTM Guardian Consulting Services, Inc. (855) 675-6235 whallett@guardianconsulting.com

More information

NURSING FACILITY ASSESSMENTS

NURSING FACILITY ASSESSMENTS Department of Health and Human Services OFFICE OF INSPECTOR GENERAL NURSING FACILITY ASSESSMENTS AND CARE PLANS FOR RESIDENTS RECEIVING ATYPICAL ANTIPSYCHOTIC DRUGS Daniel R. Levinson Inspector General

More information

Survey Protocol for Long Term Care Facilities

Survey Protocol for Long Term Care Facilities Attachment B Survey Protocol for Long Term Care Facilities The provision of home dialysis treatments in a Long Term Care (LTC) facility place an increased burden on the LTC facility staff and may place

More information

Informal Dispute Resolution Finding Your Seat at the Table

Informal Dispute Resolution Finding Your Seat at the Table Informal Dispute Resolution Finding Your Seat at the Table Jennifer L. Hardesty, PharmD, FASCP Chief Clinical Officer, Corporate Compliance Officer Remedi SeniorCare William M. Vaughan BSN, RN Vice President,

More information

Based on the comprehensive assessment of a resident, the facility must ensure that:

Based on the comprehensive assessment of a resident, the facility must ensure that: 7. QUALITY OF CARE Each resident must receive, and the facility must provide, the necessary care and services to attain or maintain the highest practicable physical, mental and psychosocial wellbeing,

More information

SUMMARY OF KEY FINDINGS FROM THE FAWN RIDGE ADULT HOME ENFORCEMENT DECISION 1 CHARGE #3

SUMMARY OF KEY FINDINGS FROM THE FAWN RIDGE ADULT HOME ENFORCEMENT DECISION 1 CHARGE #3 SUMMARY OF KEY FINDINGS FROM THE FAWN RIDGE ADULT HOME ENFORCEMENT DECISION 1 CHARGE #3 REGULATION: 18 NYCRR 487.7(d)(1) - Resident Services Supervision services shall include, but are not limited to:

More information

Medication Management, Regulations and Resident Centered Care: What Could Possibly Go Wrong?

Medication Management, Regulations and Resident Centered Care: What Could Possibly Go Wrong? PACAH Spring Conference April 29,2016 Medication Management, Regulations and Resident Centered Care: What Could Possibly Go Wrong? Jennifer L. Hardesty, PharmD, FASCP Chief Clinical Officer Corporate Compliance

More information

CMS RAI MANUAL ERRATA DOCUMENT

CMS RAI MANUAL ERRATA DOCUMENT CMS RAI MANUAL ERRATA DOCUMENT SECTION I UTI S In Chapter 3, page I-9, under Coding Tips in I: Active Diagnoses in the Last 7 Days, a third bullet has been added: If the diagnosis of UTI was made prior

More information

Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities Proposed Rule

Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities Proposed Rule Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities Proposed Rule Summary of Major Provisions Summary adapted from Proposed Rule (with AHCA Comments) July 14, 2015 Updates

More information

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that hospital. 1 2 3 Note that an actual variance occurs when

More information

Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care

Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care Notes from CMS Final Rule Document Pertinent to Culture Change and Person-directed Care Page 594 Prepared by Cathy Lieblich, Director of Network Relations, Pioneer Network G. Benefits of Final Rule: This

More information

Antibiotics - Are they OVERUSED? 4/6/2018. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes. Pathway Health 1.

Antibiotics - Are they OVERUSED? 4/6/2018. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes. Pathway Health 1. Antibiotic Stewardship Key Clinical Strategies for Successful Outcomes Louann Lawson, BA, RN, RAC-CT, CIMT Nurse Consultant Clinical Reimbursement Team Leader/Clinical Education Manager Pathway Health

More information

MINNESOTA. Downloaded January 2011

MINNESOTA. Downloaded January 2011 MINNESOTA Downloaded January 2011 4658.1300 MEDICATIONS AND PHARMACY SERVICES; DEFINITIONS. Subpart 1. Controlled substances. "Controlled substances" has the meaning given in Minnesota Statutes, section

More information

Antibiotic Stewardship Program (ASP)

Antibiotic Stewardship Program (ASP) Introduction: Antibiotics are among the most frequently prescribed medications in nursing centers, with up to 70% of nursing home patients receiving one or more courses of systemic antibiotics in a year.

More information

Center for Clinical Standards and Quality/Survey & Certification Group

Center for Clinical Standards and Quality/Survey & Certification Group DRAFT DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2 21 16 Baltimore, Maryland 21244-1850 Center for Clinical Standards and Quality/Survey

More information

Pharmaceutical Services Report to Joint Conference Committee September 2010

Pharmaceutical Services Report to Joint Conference Committee September 2010 Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory

More information

Antimicrobial Stewardship Program in the Nursing Home

Antimicrobial Stewardship Program in the Nursing Home Antimicrobial Stewardship Program in the Nursing Home CAHF San Bernardino/Riverside Chapter May 19 th, 2016 Presented by Robert Jackson, Pharm.D. Pharmaceutical Consultant II, Specialist CDPH Licensing

More information

Center for Clinical Standards and Quality/Survey & Certification Group

Center for Clinical Standards and Quality/Survey & Certification Group DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Center for Clinical Standards and Quality/Survey

More information

OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management

OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management OIG Risk Areas: Comprehensive Care Plans, Restorative/Personal Care Services & Medication Management Presented by: Nan Impink, Esq. Kelly Priegnitz, Esq. Harvey Tettlebaum, Esq. Where We ve Been & Today

More information

Get Ready for Phase 1 of the New Requirements of Participation

Get Ready for Phase 1 of the New Requirements of Participation Pennsylvania Health Care Association November 7, 2016 Get Ready for Phase 1 of the New Requirements of Participation Paula G. Sanders, Esquire Post & Schell, P.C. Gail Weidman Dawn Murr-Davidson Pennsylvania

More information

5. returning the medication container to proper secured storage; and

5. returning the medication container to proper secured storage; and 111-8-63-.20 Medications. (1) Self-Administration of Medications. Residents who have the cognitive and functional capacities to engage in the self-administration of medications safely and independently

More information

Monitoring Medication Storage & Administration

Monitoring Medication Storage & Administration Monitoring Medication Storage & Administration Objectives Review F-Tags pertaining to medication management Discuss proper medication storage and administration Understand medication cart and medication

More information

University of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation

University of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation University of Mississippi Medical Center University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation TJC Standards for Medication Management March 2012 Purpose The

More information

NORTH CAROLINA. Downloaded January 2011

NORTH CAROLINA. Downloaded January 2011 NORTH CAROLINA Downloaded January 2011 10A NCAC 13D.2306 MEDICATION ADMINISTRATION (a) The facility shall ensure that medications are administered in accordance with standards of professional practice

More information

DEFINITIONS (c)(1) Discharge Planning : Home Health Agency (HHA) : Inpatient Rehabilitation Facility (IRF) : Local Contact Agency :

DEFINITIONS (c)(1) Discharge Planning : Home Health Agency (HHA) : Inpatient Rehabilitation Facility (IRF) : Local Contact Agency : F660 483.21(c)(1) Discharge Planning Process The facility must develop and implement an effective discharge planning process that focuses on the resident s discharge goals, the preparation of residents

More information

PACAH 2018 SPRING CONFERENCE April 26, 2018

PACAH 2018 SPRING CONFERENCE April 26, 2018 PACAH 2018 SPRING CONFERENCE April 26, 2018 Presented by Tanya Daniels Harris, Esq. 2018 LATSHA DAVIS & McKENNA, P.C. 2 OVERVIEW OF RECENT SURVEY AND ENFORCEMENT ISSUES Performance Audit of DOH Regulation

More information

Clinical Intervention Overview: Objectives

Clinical Intervention Overview: Objectives AHRQ Safety Program for Long-term Care: HAIs/CAUTI Clinical Intervention Overview: Preventing Infections to Enhance Resident Safety Cohort 5 Learning Session #1 Steven J. Schweon RN, CIC APIC Infection

More information

Preventing Medical Errors

Preventing Medical Errors Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.

More information

4/3/2018. Nursing Facility Changes to Conditions of Participation (& Enforcement): What You Need to Know. Revisions to State Operations Manual

4/3/2018. Nursing Facility Changes to Conditions of Participation (& Enforcement): What You Need to Know. Revisions to State Operations Manual DAVIS, BROWN, KOEHN, SHORS & ROBERTS, 1P.C. Nursing Facility Changes to Conditions of Participation (& Enforcement): What You Need to Know Lynn Böes and Ken Watkins 2 Revisions to State Operations Manual

More information

A. BUILDING 8/14/2008 2:00:30PM LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE

A. BUILDING 8/14/2008 2:00:30PM LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE (X1) PROVER/SUPPLIER/CLIA ENTIFICATION NUMBER: (X3) SURVEY D NAME OF PROVER OR SUPPLIER KAISER FOUNDATION HOSPITAL, RIVERSE 10800 MAGNOLIA AVENUE, RIVERSE, CA 92505 RIVERSE COUNTY (X4) SUMMARY REGULATORY

More information

483.10(b)(4) and (8) Rights Regarding Advance Directives, Treatment, and Experimental Research

483.10(b)(4) and (8) Rights Regarding Advance Directives, Treatment, and Experimental Research 483.10(b)(4) and (8) Rights Regarding Advance Directives, Treatment, and Experimental Research (F155) Surveyor Training of Trainers: Interpretive Guidance Investigative Protocol Federal Regulatory Language

More information

Mood Stabilizers: Medications used to even out the mood swings experienced by a person with bipolar disorder.

Mood Stabilizers: Medications used to even out the mood swings experienced by a person with bipolar disorder. Title: County of Sacramento Department of Health and Human Services Division of Behavioral Health Services Policy and Procedure Policy Issuer (Unit/Program) Policy Number QM QM-10-32 Effective Date 04-22-2016

More information

Patient Centered Care Planning and Behaviors. Presented by: Pam Paulsen, RN/BC,RAC-CT Angela Johnson, PharmD, BCGP

Patient Centered Care Planning and Behaviors. Presented by: Pam Paulsen, RN/BC,RAC-CT Angela Johnson, PharmD, BCGP Patient Centered Care Planning and Behaviors Presented by: Pam Paulsen, RN/BC,RAC-CT Angela Johnson, PharmD, BCGP Objectives 1 2 3 Identify 3 ways to promote patient centered care throughout communication

More information

QAA/QAPI Meeting Agenda Guide

QAA/QAPI Meeting Agenda Guide QAA/QAPI Meeting Agenda Guide Date of Meeting The facility is required to have a QAA committee (do not need to use this name) that meets at least quarterly and as needed to coordinate and evaluate activities

More information

CMS PROPOSED REVISIONS OF THE NURSING HOME REGULATIONS

CMS PROPOSED REVISIONS OF THE NURSING HOME REGULATIONS We are almost done here for the day! CMS PROPOSED REVISIONS OF THE NURSING HOME REGULATIONS SNF Regulatory Day September 17, 2015 CMS s Major Initiatives Reduce unnecessary readmissions Reduce Healthcare

More information

CRAIG HOSPITAL POLICY/PROCEDURE

CRAIG HOSPITAL POLICY/PROCEDURE CRAIG HOSPITAL POLICY/PROCEDURE Approved: P&T, MEC, NPC, P&P 03/09 Effective Date: 02/95 P&T, MEC, P&P 08/09; P&P 08/10; P&T, MEC 10/10, P&T, P&P 12/10 ; MEC 01/11; P&T, MEC 02/11, 04/11 ; P&T, P&P 12/11

More information

Advanced Practice Provider (APP): Nurse Practitioner (NP) or Physician s Assistant (PA).

Advanced Practice Provider (APP): Nurse Practitioner (NP) or Physician s Assistant (PA). GEORGIA DEPARTMENT OF JUVENILE JUSTICE Applicability: { } All DJJ Staff { } Administration { } Community Services {x} Secure Facilities (RYDC and YDC) Transmittal # 17-15 Policy # 11.26 Related Standards

More information

Improving Primary Care Medication Patient Safety: System-level Medication Adherence Issues

Improving Primary Care Medication Patient Safety: System-level Medication Adherence Issues Improving Primary Care Medication Patient Safety: System-level Medication Adherence Issues Marie Smith, PharmD Professor and Asst. Dean, Practice and Public Policy Partnerships Meg Mello Moniz, PharmD

More information

5/1/2017 THE BEST DEFENSE IS A GOOD OFFENSE OBJECTIVES. Preparing for a Home Health Medicare Recertification Survey

5/1/2017 THE BEST DEFENSE IS A GOOD OFFENSE OBJECTIVES. Preparing for a Home Health Medicare Recertification Survey THE BEST DEFENSE IS A GOOD OFFENSE Preparing for a Home Health Medicare Recertification Survey OBJECTIVES To gain an understanding how the Medicare Conditions of Participation (CoPs), the individual G-tags,

More information

Core Elements of Antibiotic Stewardship for Nursing Homes

Core Elements of Antibiotic Stewardship for Nursing Homes Core Elements of Antibiotic Stewardship for Nursing Homes Welcome! Holly Harmon, RN, MBA, LNHA Senior Director Clinical Services 1 Leonard Russ Immediate Past Chair AHCA Board of Governors Antibiotic Stewardship

More information

NEW JERSEY. Downloaded January 2011

NEW JERSEY. Downloaded January 2011 NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if

More information

Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2

Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2 Federal Requirements of Participation for Nursing Homes Summary of Key Changes in the Final Rule Issued September 2016 Phase 2 On September 28, 2016, the Centers for Medicare & Medicaid Services (CMS)

More information

COMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016

COMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016 COMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016 INTRODUCTION Incidents as part of COMPASS (Community Pharmacists Advancing Safety in Saskatchewan) Phase II reported by 87

More information

Section N Medications

Section N Medications Instructor Guide Section N Medications Objectives At the conclusion of this lesson, the student will be able to: State the intent of Section N Medications. Describe the information required to complete

More information

PERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN

PERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN Resident-to-Resident Assaults AIM: To decrease incidents of Resident to Residents assaults by 5% in the Fiscal Year (FY) 2011-2012. MONITORING: Data is collected from all instances in which State of California

More information

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

CONSULTANT PHARMACIST INSPECTION LAW REVIEW CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted

More information

Safe Medication Assistance and Administration Policy

Safe Medication Assistance and Administration Policy Safe Medication Assistance and Administration Policy It is the policy of New Challenges Inc. to provide safe medication setup, assistance and administration: When assigned responsibility in the person

More information

Optimizing Medication Safety in Maryland Assisted Living Facilities. Panel Discussion Moderated by: Nicole Brandt, PharmD

Optimizing Medication Safety in Maryland Assisted Living Facilities. Panel Discussion Moderated by: Nicole Brandt, PharmD Optimizing Medication Safety in Maryland Assisted Living Facilities Panel Discussion Moderated by: Nicole Brandt, PharmD 11 Objectives At the end of this knowledge based activity, the participants should

More information

Pharmaceutical Services Requirements: formerly 10D and 10C.7

Pharmaceutical Services Requirements: formerly 10D and 10C.7 Pharmaceutical Services Requirements: formerly 10D.28-29 and 10C.7 Frank S. Emanuel, Pharm.D., FASHP Associate Professor/Division Director Florida A and M University College of Pharmacy Jacksonville Disclosure

More information

Rules of Participation, Phase 1 Review

Rules of Participation, Phase 1 Review 1 Rules of Participation, Phase 1 Review A Foundation check to launch Phase 2 from Presented by: Anabelle Locsin, RN, Ed.D., RAC-CT, LNC Quality Improvement Consultant PROGRAM OVERVIEW 2 This program was

More information

Interim Final Interpretive Guidelines Version 1.1

Interim Final Interpretive Guidelines Version 1.1 Interim Final Interpretive Guidelines Version 1.1 Big Changes from November 2008 to January 2009 418.54 Condition of participation: Initial and Comprehensive assessment of the patient L522 418.54(a) Standard:

More information

Succeeding in the Post-Acute Market Strive for 5 Effective Communication with Physicians, Hospitals and Other Partners and Miscellaneous Other Topics

Succeeding in the Post-Acute Market Strive for 5 Effective Communication with Physicians, Hospitals and Other Partners and Miscellaneous Other Topics Succeeding in the Post-Acute Market Strive for 5 Effective Communication with Physicians, Hospitals and Other Partners and Miscellaneous Other Topics Luis L Gonzalez, Jr, MD FACP FAAHPM CMD Objectives

More information

Get Ready for Phase 1 of the New Requirements of Participation

Get Ready for Phase 1 of the New Requirements of Participation PADONA Convention March 30, 2017 Get Ready for Phase 1 of the New Requirements of Participation Paula G. Sanders, Esquire New Requirements of Participation (RoPs) Published October 4, 2016 (81 Fed. Reg.

More information

Medication Control and Distribution. Minor/technical revision of existing policy. ± Major revision of existing policy Reaffirmation of existing policy

Medication Control and Distribution. Minor/technical revision of existing policy. ± Major revision of existing policy Reaffirmation of existing policy Name of Policy: Policy Number: 3364-133-17 Department: Pharmacy Approvingofficer: Chief Executive Officer THE unrversity OF TOLEDO MEDICAL CERITER Responsible Agent: Scope: Director of Pharmacy University

More information

Policies and Procedures for LTC

Policies and Procedures for LTC Policies and Procedures for LTC Strictly confidential This document is strictly confidential and intended for your facility only. Page ii Table of Contents 1. Introduction... 1 1.1 Purpose of this Document...

More information

An Overview of the new LTCF Requirements of Participation: Are You Ready?

An Overview of the new LTCF Requirements of Participation: Are You Ready? An Overview of the new LTCF Requirements of Participation: Are You Ready? David Gifford MD MPH Sr VP for Quality & Regulatory Affairs Feb 9 th 2017 3:15 pm 4:45 pm Boise ID CMS Changes to SNF Regs New

More information

Role of Clinical Pharmacist in Primary Care Clinic HYOJIN SUNG, PHARM.D SALEM HEALTH MEDICAL GROUP OSMA ANNUAL CONFERENCE APRIL 14, 2018

Role of Clinical Pharmacist in Primary Care Clinic HYOJIN SUNG, PHARM.D SALEM HEALTH MEDICAL GROUP OSMA ANNUAL CONFERENCE APRIL 14, 2018 Role of Clinical Pharmacist in Primary Care Clinic HYOJIN SUNG, PHARM.D SALEM HEALTH MEDICAL GROUP OSMA ANNUAL CONFERENCE APRIL 14, 2018 Objectives Understand the scope of practice for pharmacist and role

More information

Final Rule to Reform the Requirements for Long-Term Care Facilities

Final Rule to Reform the Requirements for Long-Term Care Facilities Final Rule to Reform the Requirements for Long-Term Care Facilities Karen Tritz Division of Nursing Homes Director Clinical Standards Group Long-Term Care Team Survey & Certification Group Division of

More information

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists

Scotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince

More information

Overview of the New Long-Term Care Survey Process FOR LONG-TERM CARE (LTC) PROVIDERS

Overview of the New Long-Term Care Survey Process FOR LONG-TERM CARE (LTC) PROVIDERS Overview of the New Long-Term Care Survey Process FOR LONG-TERM CARE (LTC) PROVIDERS Navigation To Start the training, please press Function + F5 To advance through each slide use the icon located at the

More information

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software.

This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. Perindopril New To Therapy Program PROTOCOL This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. April 2015 Table of Contents Executive Summary...

More information

Medical Director Requirements for Nursing Facilities Advance Issuance of Revised Survey Guidance HIGHLIGHTS

Medical Director Requirements for Nursing Facilities Advance Issuance of Revised Survey Guidance HIGHLIGHTS Medical Director Requirements for Nursing Facilities Advance Issuance of Revised Survey Guidance HIGHLIGHTS On April 9, 2005 the Centers for Medicare and Medicaid Services (CMS) released revised interpretive

More information

a. The Care Plan dated 2/16/10 documented the following:

a. The Care Plan dated 2/16/10 documented the following: b. The Plan of Care dated 1/12/10 documented, "Problem: At risk for depression, related to very young to be in long term care facility and permanent brain damage R/T [related to] trauma. Approaches: Arrange

More information

NURSING HOME SURVEILLANCE UPDATE

NURSING HOME SURVEILLANCE UPDATE NURSING HOME SURVEILLANCE UPDATE Shelly Glock, Acting Director Division of Nursing Homes and ICF/IID Surveillance Center for Health Care Provider Services and Oversight Office of Primary Care and Health

More information

GENERAL MEDICATION PROCEDURES

GENERAL MEDICATION PROCEDURES GENERAL MEDICATION PROCEDURES In situations where services will be provided in the person s own home or with their family, guardian / responsible party, medication storage, ordering and receiving medications

More information

Administration of Medications A Self-Assessment Guide for Licensed Practical Nurses

Administration of Medications A Self-Assessment Guide for Licensed Practical Nurses Administration of Medications A Self-Assessment Guide for Licensed Practical Nurses March 2018 College of Licensed Practical Nurses of Nova Scotia http://clpnns.ca Starlite Gallery, 302-7071 Bayers Road,

More information

Agenda: Noon Overview of the regulatory sections affected by the Reform of RoP in Phase 2

Agenda: Noon Overview of the regulatory sections affected by the Reform of RoP in Phase 2 Webinar: Driving Five Star & RoP Implementation Through a QAPI Approach: Final Rule: Integrating Phase 2 New Requirements of Participation into Practice (Part 1) Presentation Date: 02/15/17 Live Webinar

More information

THE BIG PICTURE. The Impact of Survey In THE SURVEY & ENFORCEMENT SESSION: WHAT HAS CHANGED? OHCA Annual Convention/April 29, 2015

THE BIG PICTURE. The Impact of Survey In THE SURVEY & ENFORCEMENT SESSION: WHAT HAS CHANGED? OHCA Annual Convention/April 29, 2015 THE SURVEY & ENFORCEMENT SESSION: WHAT HAS CHANGED? OHCA Annual Convention/April 29, 2015 Carol Rolf Christopher M. Tost Rolf Goffman Martin Lang LLP THE BIG PICTURE The Impact of Survey In 2015 Reputation

More information